Get to know the PhRMA Foundation’s award recipients.
Creating a Noninvasive Test for Monitoring Cancer Treatment Response
Dr. Liangliang Hao aims to address inequities in cancer treatment by developing a rapid point-of-care test that will predict the efficacy of certain cancer therapies.Read More
Improving Diagnosis of Systemic Amyloidosis With AI
Dr. Nir Pillar of the University of California, Los Angeles, seeks to combine novel microscopy methodologies and artificial intelligence to improve detection of systemic amyloidosis.Read More
Understanding the Impact of Financial Toxicity on Cancer Patients
Ruiqi Jin, a 2023 PhRMA Foundation predoctoral awardee, is studying how the financial burden associated with cancer affects patients and what could be changed to help.Read More
Armoring Viruses to Fight Antibiotic Resistant Infections
Antibiotic resistance is an urgent public health threat that PhRMA Foundation awardee Dr. Kevin Yehl of Miami University is working to help solve. He received a 2023 PhRMA Foundation Faculty Starter Grant in Drug Delivery for his research synthesizing “stealth” phage therapies that can reach the infection site while maintaining therapeutic efficacy. Watch this video to learn about Yehl and his research.
- University of Maryland, Eastern Shore
“Receiving the PhRMA Foundation Predoctoral Fellowship is truly a professional and personal achievement. This support will allow me to continue my efforts in drug discovery research to address the need for novel anti-seizure agents. ”